Skip to main content
main-content

08.04.2018 | Management of Heart Failure (T. Meyer, Section Editor) | Ausgabe 3/2018

Current Heart Failure Reports 3/2018

Has the Time Come to Be More Aggressive With Bariatric Surgery in Obese Patients With Chronic Systolic Heart Failure?

Zeitschrift:
Current Heart Failure Reports > Ausgabe 3/2018
Autor:
Amanda R. Vest
Wichtige Hinweise
This article is part of the Topical Collection on Management of Heart Failure

Abstract

Purpose of Review

Obesity is a strong risk factor for the development of heart failure (HF). Diet, exercise, and weight-loss pharmacotherapies have limited potential to achieve significant and sustainable weight loss, especially in patients with symptomatic systolic HF. This review seeks to determine the role of bariatric surgery for patients with systolic HF and obesity.

Recent Findings

Bariatric surgeries such as the laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) represent the most successful long-term strategy for achieving weight loss and diabetes and hypertension remission in the general obese population. These benefits translate to reductions in cardiovascular events and mortality, as well as improvements in myocardial structure and function. There is also now data supporting the safety of LSG or RYGB in patients with systolic dysfunction and a reduction in HF admissions post-operatively.

Summary

Current literature and clinical experience suggest that the most appropriate bariatric surgery candidates with HF are patients aged < 50–60 years, with severely depressed systolic function and NYHA II-III symptoms, who have failed non-surgical strategies and have a high likelihood of future cardiac transplantation candidacy after weight loss. This review seeks to determine the role of bariatric surgery for patients with systolic HF and obesity.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Bis zum 22.10. bestellen und 100 € sparen!

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2018

Current Heart Failure Reports 3/2018Zur Ausgabe

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Management of Sleep Disordered Breathing in Patients with Heart Failure

Management of Heart Failure (T. Meyer, Section Editor)

Essential Elements of Early Post Discharge Care of Patients with Heart Failure

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Novel Insights and Treatment Strategies for Right Heart Failure

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Nutritional Interventions in Heart Failure: Challenges and Opportunities

  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Kardiologie

 

 

 
 

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise